Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0021641,
umls-concept:C0030685,
umls-concept:C0037659,
umls-concept:C0060993,
umls-concept:C0086045,
umls-concept:C0086376,
umls-concept:C0127400,
umls-concept:C0301625,
umls-concept:C0301630,
umls-concept:C0391871,
umls-concept:C0521449,
umls-concept:C0596235,
umls-concept:C0680255,
umls-concept:C1280500,
umls-concept:C1283071,
umls-concept:C1314939,
umls-concept:C1880497,
umls-concept:C1963578,
umls-concept:C1996904
|
pubmed:issue |
2
|
pubmed:dateCreated |
1989-2-17
|
pubmed:abstractText |
The effects of galanin and somatostatin on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration [( Ca2+]i) were investigated using beta-cells isolated from obese hyperglycemic mice. Whereas insulin release was measured in a column perifusion system, membrane potential and [Ca2+]i were measured with the fluorescent indicators bisoxonol (bis-(1,3-diethylthiobarbiturate)trimethineoxonol) and quin 2, in cell suspensions in a cuvette. Galanin (16 nM) and somatostatin (400 nM) suppressed glucose-stimulated insulin release in parallel to promoting repolarization and a reduction in [Ca2+]i. The reduction in [Ca2+]i comprised an initial nadir followed by a slow rise and the establishment of a new steady state level. The slow rise in [Ca2+]i was abolished by 50 microM D-600, a blocker of voltage-activated Ca2+ channels. Both peptides suppressed insulin release even when [Ca2+]i was raised by 25 mM K+. Under these conditions the inhibition of insulin release was partly reversed by an increase in the glucose concentration. Addition of 5 mM Ca2+ to a cell suspension, incubated in the presence of 20 mM glucose and either galanin, somatostatin, or the alpha 2-adrenergic agonist clonidine (10 nM), induced oscillations in [Ca2+]i, this effect disappearing subsequent to the addition of D-600. The effects of galanin, somatostatin, and clonidine on [Ca2+]i were abolished in beta-cells treated with pertussis toxin. In accordance with measurements of [Ca2+]i, treatment with pertussis toxin reversed the inhibitory effect of galanin on insulin release. The inhibitory action of galanin and somatostatin on insulin release is probably accounted for by not only a repolarization-induced reduction in [Ca2+]i and a decreased sensitivity of the secretory machinery to Ca2+, but also by a direct interaction with the exocytotic process. It is proposed that these effects are mediated by a pertussis toxin-sensitive GTP-binding protein.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Galanin,
http://linkedlifedata.com/resource/pubmed/chemical/Gallopamil,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
973-80
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2463254-Animals,
pubmed-meshheading:2463254-Calcium,
pubmed-meshheading:2463254-Cell Membrane,
pubmed-meshheading:2463254-Female,
pubmed-meshheading:2463254-GTP-Binding Proteins,
pubmed-meshheading:2463254-Galanin,
pubmed-meshheading:2463254-Gallopamil,
pubmed-meshheading:2463254-Glucose,
pubmed-meshheading:2463254-Hyperglycemia,
pubmed-meshheading:2463254-Insulin,
pubmed-meshheading:2463254-Islets of Langerhans,
pubmed-meshheading:2463254-Kinetics,
pubmed-meshheading:2463254-Male,
pubmed-meshheading:2463254-Membrane Potentials,
pubmed-meshheading:2463254-Mice,
pubmed-meshheading:2463254-Mice, Obese,
pubmed-meshheading:2463254-Neuropeptides,
pubmed-meshheading:2463254-Peptides,
pubmed-meshheading:2463254-Potassium,
pubmed-meshheading:2463254-Somatostatin
|
pubmed:year |
1989
|
pubmed:articleTitle |
Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration.
|
pubmed:affiliation |
Department of Medical Cell Biology, Uppsala University, Sweden.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|